Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
34.46
-0.43 (-1.23%)
Aug 20, 2026, 3:10 PM EDT - Market open
Alto Neuroscience Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
68
Market Cap
1.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 210.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
ANRO News
- 3 days ago - Alto Neuroscience price target raised to $55 from $50 at H.C. Wainwright - TheFly
- 3 days ago - Alto Neuroscience reports Q EPS (65c), consensus (77c) - TheFly
- 3 days ago - Alto Neuroscience price target raised to $37 from $28 at BTIG - TheFly
- 4 days ago - Alto Neuroscience price target raised to $37 from $33 at BofA - TheFly
- 7 days ago - Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Business Wire
- 7 days ago - Alto Neuroscience Earnings release: Q2 2026 - Filings
- 7 days ago - Alto Neuroscience Quarterly report: Q2 2026 - Filings
- 8 days ago - Alto Neuroscience Slides: Corporate presentation - Filings